$47.27
-2.16 (-4.37%)
At Close: Jul 31, 2026
Torex Gold Reports Q3 2024 Production Results
06:00pm, Tuesday, 08'th Oct 2024
Solidly on track to deliver full-year production guidance following strong third quarter results Toronto, Ontario--(Newsfile Corp. - October 8, 2024) - Torex Gold Resources Inc. (the "Company" or "Tor
10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting
04:05pm, Tuesday, 01'st Oct 2024
PLEASANTON, Calif. , Oct. 1, 2024 /PRNewswire/ -- At the Human Cell Atlas General Meeting held September 29-30 in Milan, Italy, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial bi
Torex Gold Welcomes the Addition of a New Director
06:00pm, Monday, 23'rd Sep 2024
Caroline Donally brings extensive mining sector experience in commerce and financial markets Toronto, Ontario--(Newsfile Corp. - September 23, 2024) - Torex Gold Resources Inc. (the "Company" or "Tore
In the September 9 cover article of Cancer Cell, researchers integrated 10x single cell and spatial technologies to identify a mechanism of glioblastoma recurrence in mice and develop a promising pot
Torex Gold Integrates EPO Deposit into Morelos Mine Plan
06:00pm, Wednesday, 04'th Sep 2024
Updated mine plan shows a robust long-term production profile that comes with a low risk, capital efficient development plan for EPO (All amounts expressed in U.S. dollars unless otherwise stated) Tor
10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research
04:05pm, Tuesday, 03'rd Sep 2024
PLEASANTON, Calif. , Sept. 3, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Chromium Xo, a new addition to its fle
Torex Gold Reports a Contractor Fatality at the Morelos Complex
12:15pm, Thursday, 29'th Aug 2024
Toronto, Ontario--(Newsfile Corp. - August 29, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) announces that on the morning of August 29th, a fatal injury occurred involving a
10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
04:05pm, Thursday, 22'nd Aug 2024
PLEASANTON, Calif. , Aug. 22, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate i
10x Genomics, Inc. (TXG) Q2 2024 Earnings Call Transcript
10:42pm, Thursday, 08'th Aug 2024
10x Genomics, Inc. (NASDAQ:TXG ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Cassie Corneau - Director-Investor Relations & Strategic Finance Serge Saxonov - Chief
10x Genomics (TXG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
07:01pm, Thursday, 08'th Aug 2024
While the top- and bottom-line numbers for 10x Genomics (TXG) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compar
10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates
06:46pm, Thursday, 08'th Aug 2024
10x Genomics (TXG) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.53 per share a year ago.
10x Genomics Announces Senior Leadership Changes
04:05pm, Thursday, 08'th Aug 2024
PLEASANTON, Calif. , Aug. 8, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today several changes to its executive team.
10x Genomics Reports Second Quarter 2024 Financial Results
04:04pm, Thursday, 08'th Aug 2024
PLEASANTON, Calif. , Aug. 8, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter ended June 3
Torex Gold Reports Q2 2024 Results
06:00pm, Wednesday, 07'th Aug 2024
Another consistent quarter of safe and reliable production; on track to deliver on full-year operational guidance (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(New
Unlocking Q2 Potential of 10x Genomics (TXG): Exploring Wall Street Estimates for Key Metrics
10:20am, Wednesday, 07'th Aug 2024
Besides Wall Street's top -and-bottom-line estimates for 10x Genomics (TXG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during th
Sign In
Buy TXG